We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Early Diagnosis of Tularemia Accomplished by Flow Cytometry

By LabMedica International staff writers
Posted on 02 Oct 2019
Print article
Image: The Navios Flow Cytometer offers a solution for advanced cytometry applications with workflows for high throughput laboratories (Photo courtesy of Beckman Coulter).
Image: The Navios Flow Cytometer offers a solution for advanced cytometry applications with workflows for high throughput laboratories (Photo courtesy of Beckman Coulter).
Tularemia is a zoonotic disease that occurs in the Northern Hemisphere and is caused by Francisella tularensis. In Europe, more than 500 cases are reported annually and Turkey and the USA also have substantial disease burdens.

No clinical or laboratory manifestations are pathognomonic for tularemia; preliminary diagnosis is based on exposure risk and compatible clinical presentation. Clinical manifestations include the ulceroglandular, glandular, oroglandular, and oculoglandular forms; septicemic (typhoidal) form; and respiratory form.

Scientists from the České Budějovice Hospital (České Budějovice, Czech Republic) and their colleagues used laboratory records and local hospital and unit diagnostic indices, and retrospectively identified all cases of tularemia that were managed in the infectious disease units at two hospital during January 1, 2003, through December 31, 2015. The control group included a consecutive group of ill adults who were investigated for possible tularemia in the same two units during January 1, 2012, through December 31, 2015.

For serologic testing, the team used a commercial agglutination test, the Tularemia Diagnostic Set. They also performed blood cultures using BacT/ALERT 3D and species was determined by polymerase chain reaction (PCR). The investigators used a flow cytometry–based test for quantifying the percentage of CD3+ T cells with the CD4–/CD8– phenotype for predicting tularemia. The samples were processed using either a Cytomics FC500 (before 2014) or Navios (starting in 2013) flow cytometer and CXP (for Cytomics FC500).

The team reported that the median percentage of CD3+/CD4–/CD8– T cells in peripheral blood was higher in tularemia patients (19%, 95% CI 17%–22%) than in controls (3%, 95% CI 2%–3%). When they used 8% as the cutoff, this test’s sensitivity was 0.953 and specificity 0.895 for distinguishing cases from controls. The CD3+/CD4–/CD8– T cells increased a median of seven days before tularemia serologic test results became positive.

The authors concluded that flow cytometry analyses of peripheral blood samples showing a percentage of CD3+/CD4–/CD8– T cells greater than 8% supports a presumptive clinical diagnosis of tularemia and initiation of specific antimicrobial therapy days to weeks before the diagnosis can be confirmed serologically. This more rapid test is a useful addition to the diagnostic work-up for tularemia that can help public health teams managing waterborne outbreaks and inhalation infection clusters speed up diagnosis and treatment and thus contain pathogen spread. The study was published in the October 2019 issue of the journal Emerging Infectious Diseases.

Related Links:
České Budějovice Hospital

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.